Measuring the gene expression of Nrf2-target enzymes that regulate GSH synthesis and cycling can provide insight into GSH homeostasis during NAFLD and after chronic AT1 blockade. This evidence concerns the gene NFE2L2 and metabolic dysfunction-associated steatotic liver disease.